REPL
Price
$9.94
Change
-$1.05 (-9.55%)
Updated
Jul 13 closing price
Capitalization
834M
16 days until earnings call
Intraday BUY SELL Signals
SPRY
Price
$7.74
Change
-$0.20 (-2.52%)
Updated
Jul 13 closing price
Capitalization
769.1M
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

REPL vs SPRY

REPL vs SPRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
REPL vs. SPRY commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REPL is a StrongBuy and SPRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (REPL: $9.94 vs. SPRY: $7.74)
Brand notoriety: REPL and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REPL: 30% vs. SPRY: 46%
Market capitalization -- REPL: $834M vs. SPRY: $769.1M
REPL [@Biotechnology] is valued at $834M. SPRY’s [@Biotechnology] market capitalization is $769.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REPL’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • REPL’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, REPL is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REPL’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • REPL’s TA Score: 4 bullish, 5 bearish.
  • SPRY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, REPL is a better buy in the short-term than SPRY.

Price Growth

REPL (@Biotechnology) experienced а -13.38% price change this week, while SPRY (@Biotechnology) price change was -7.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

REPL is expected to report earnings on Jul 30, 2026.

SPRY is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REPL($834M) has a higher market cap than SPRY($769M). REPL YTD gains are higher at: 2.212 vs. SPRY (-33.562). SPRY has higher annual earnings (EBITDA): -90.79M vs. REPL (-303.89M). SPRY has more cash in the bank: 288M vs. REPL (269M). REPL has less debt than SPRY: REPL (76.3M) vs SPRY (97.8M). SPRY has higher revenues than REPL: SPRY (143M) vs REPL (0).
REPLSPRYREPL / SPRY
Capitalization834M769M108%
EBITDA-303.89M-90.79M335%
Gain YTD2.212-33.562-7%
P/E RatioN/A151.25-
Revenue0143M-
Total Cash269M288M93%
Total Debt76.3M97.8M78%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REPLSPRY
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
REPL
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PABGX205.11N/A
N/A
T. Rowe Price Blue Chip Growth Advisor
FSDAX29.22N/A
N/A
Fidelity Select Defense & Aerospace
AVEGX57.37N/A
N/A
Ave Maria Growth
KMDVX34.68N/A
N/A
Keeley Gabelli Mid Cap Dividend A
SGIGX38.46N/A
N/A
Steward Global Equity Income Fund R6

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-2.52%
LPCN - SPRY
63%
Loosely correlated
-2.49%
LXEO - SPRY
33%
Loosely correlated
-3.63%
TSHA - SPRY
32%
Poorly correlated
-15.14%
GLSI - SPRY
32%
Poorly correlated
-6.21%
REPL - SPRY
31%
Poorly correlated
-9.60%
More